Novonesis Q1 Organic Growth Exceeds Expectations, Strong Performance in Food & Beverages Sector
AI summary card
Novonesis Q1 Organic Growth Exceeds Expectations, Strong Performance in Food & Beverages Sector
Q1 2026 organic growth of 7% exceeded market expectations, with Food & Beverages sector growing 11% as the main driver, while profitability remained robust.
- 1Q26 organic growth of 7%, surpassing market expectations of 6.2%
- Food & Beverages sector growth of 11%, significantly above expectations
- Adjusted EBITDA margin of 37.8%, down 52bps year-on-year
- Maintains full-year organic growth guidance of 5-7%
- Target price Dkr475 implies 19.1% upside potential
Report interpretation
Overview
Goldman Sachs published its review of Novonesis' Q1 2026 earnings, noting that both organic growth and profitability exceeded expectations. The Food & Beverages sector performed particularly well, driving overall growth. Although some business segments fell short of expectations, the company maintained its full-year guidance, which could positively impact the stock price.
Core views
Growth: Q1 2026 organic growth of 7% was 80bps above the consensus expectation of 6.2%. The Food & Beverages sector grew 11%, significantly exceeding the expected 5.3%, driven by premiumization in dairy and cheese demand. Household Care grew 4%, above the expected 2.5%, benefiting from increased regional customer penetration. Human Health grew 5%, below the expected 8.1%, due to weak probiotic supplement demand in North America. Agriculture, Energy & Tech grew 5%, below the expected 8.7%, as plant and tech sales declined due to order timing. Profitability: Adjusted EBITDA margin was 37.8%, down slightly by 52bps year-on-year, as gross margin improvement and cost synergies were offset by higher operating expenses and currency headwinds. Food & Health Biosolutions margin was 35.7%, down 130bps; Planetary Health Biosolutions margin was 39.5%, up 10bps, benefiting from the consolidation of acquired feed enzyme operations. Outlook: Maintains FY26 organic growth guidance of 5-7%, including 1pp from pricing, 1pp from sales synergies, and approximately 1pp negative impact from exiting certain countries. Adjusted EBITDA margin is expected to be 37-38%, improving from 2025's 37.1%. The company sees no material impact from the Middle East conflict due to market diversification and regional production capabilities.
Analysis framework
Goldman Sachs employed a segment-by-segment analysis to assess growth drivers across business units, combined with organic growth breakdowns (e.g., impact of exiting countries, inventory buildup) to evaluate growth quality. Profitability analysis focused on gross margin, operating expenses, and currency impacts. Valuation used a two-stage DCF model, assuming a WACC of 7.1% and a terminal growth rate of 2.7%. The report compared consensus expectations with company guidance to assess the degree and sustainability of the earnings beat.
Methodology notes
Two-stage DCF model
Calculates intrinsic value by forecasting future free cash flows and discounting to present value, assuming a WACC of 7.1% and a terminal growth rate of 2.7% to derive the target price.
Organic growth breakdown
Decomposes growth into price, volume, and M&A/divestiture impacts, noting 1pp from pricing, 1pp from synergies, and quantifying the negative impact from exiting countries.
Margin driver analysis
Breaks down EBITDA margin changes into gross margin, operating expenses, and currency factors to assess earnings sustainability.
Key data
- 1Q26 Organic Growth7%Above consensus of 6.2%
- Food & Beverages Growth11%Above consensus of 5.3%
- Adjusted EBITDA Margin37.8%Year-on-year -52bps
- FY26 Organic Growth Guidance5-7%Unchanged
- Target PriceDkr475Implies 19.1% upside
Impact & implications
The report suggests that the strong Food & Beverages performance and better-than-expected profitability will positively impact the stock price, despite some business segments falling short. The maintained full-year guidance and limited Middle East conflict impact bolster investor confidence. The stock has underperformed peers by 1% year-to-date, presenting a potential recovery opportunity post-earnings.
Risks
- Post-acquisition integration issues may lead to higher-than-expected costs or slower growth
- Significant delays in synergy realization
- Weak Chinese consumption affecting Food & Beverages
- Lower oil prices reducing enzyme substitution appeal
- Slowing dietary supplement demand or increased competition impacting Human Health
- Weak animal nutrition demand dragging Agriculture, Energy & Tech
What to watch
- Improvement in plant and tech order timing
- Energy business run-rate and Middle East conflict impact
- Sustainability of Food & Beverages growth
- Progress in synergy realization